Mendoza N - Search Results

1

Quantitation of TGF-β proteins in mouse tissues shows reciprocal changes in TGF-β1 and TGF-β3 in normal vs neoplastic mammary epithelium.

Flanders KC, Yang YA, Herrmann M, Chen J, Mendoza N, Mirza AM, Wakefield LM. Flanders KC, et al. Among authors: mendoza n. Oncotarget. 2016 Jun 21;7(25):38164-38179. doi: 10.18632/oncotarget.9416. Oncotarget. 2016. PMID: 27203217 Free PMC article.

2

XOMA 052, an anti-IL-1β monoclonal antibody, prevents IL-1β-mediated insulin resistance in 3T3-L1 adipocytes.

Handa M, Vanegas S, Maddux BA, Mendoza N, Zhu S, Goldfine ID, Mirza AM. Handa M, et al. Among authors: mendoza n. Obesity (Silver Spring). 2013 Feb;21(2):306-9. doi: 10.1002/oby.20004. Obesity (Silver Spring). 2013. PMID: 23401297 Free article.

3

Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.

Roell MK, Issafras H, Bauer RJ, Michelson KS, Mendoza N, Vanegas SI, Gross LM, Larsen PD, Bedinger DH, Bohmann DJ, Nonet GH, Liu N, Lee SR, Handa M, Kantak SS, Horwitz AH, Hunter JJ, Owyang AM, Mirza AM, Corbin JA, White ML. Roell MK, et al. Among authors: mendoza n. J Biol Chem. 2010 Jul 2;285(27):20607-14. doi: 10.1074/jbc.M110.115790. Epub 2010 Apr 21. J Biol Chem. 2010. PMID: 20410301 Free PMC article.

4

Unusual proteolytic activation of pro-hepatocyte growth factor by plasma kallikrein and coagulation factor XIa.

Peek M, Moran P, Mendoza N, Wickramasinghe D, Kirchhofer D. Peek M, et al. Among authors: mendoza n. J Biol Chem. 2002 Dec 6;277(49):47804-9. doi: 10.1074/jbc.M209778200. Epub 2002 Oct 7. J Biol Chem. 2002. PMID: 12372819 Free article.

5

Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer.

Mendoza N, Phillips GL, Silva J, Schwall R, Wickramasinghe D. Mendoza N, et al. Cancer Res. 2002 Oct 1;62(19):5485-8. Cancer Res. 2002. PMID: 12359757

6

Selective cyclin-dependent kinase 2/cyclin A antagonists that differ from ATP site inhibitors block tumor growth.

Mendoza N, Fong S, Marsters J, Koeppen H, Schwall R, Wickramasinghe D. Mendoza N, et al. Cancer Res. 2003 Mar 1;63(5):1020-4. Cancer Res. 2003. PMID: 12615717

7

Somatic mutations lead to an oncogenic deletion of met in lung cancer.

Kong-Beltran M, Seshagiri S, Zha J, Zhu W, Bhawe K, Mendoza N, Holcomb T, Pujara K, Stinson J, Fu L, Severin C, Rangell L, Schwall R, Amler L, Wickramasinghe D, Yauch R. Kong-Beltran M, et al. Among authors: mendoza n. Cancer Res. 2006 Jan 1;66(1):283-9. doi: 10.1158/0008-5472.CAN-05-2749. Cancer Res. 2006. PMID: 16397241

8

Glucosidase inhibition assay as prescreen for natural products.

Antoun MD, Ríos YR, Mendoza NT, Proctor G. Antoun MD, et al. Among authors: mendoza nt. P R Health Sci J. 1994 Mar;13(1):13-5. P R Health Sci J. 1994. PMID: 8016289

9

Reverse transcriptase inhibition as prescreen for potential antiviral bioactives.

Antoun MD, Ríos YR, Mendoza NT, Proctor G. Antoun MD, et al. Among authors: mendoza nt. P R Health Sci J. 1994 Mar;13(1):17-8. P R Health Sci J. 1994. PMID: 7517050

10

Cytotoxicity of Hymenocallis expansa alkaloids.

Antoun MD, Mendoza NT, Ríos YR, Proctor GR, Wickramaratne DB, Pezzuto JM, Kinghorn AD. Antoun MD, et al. Among authors: mendoza nt. J Nat Prod. 1993 Aug;56(8):1423-5. doi: 10.1021/np50098a030. J Nat Prod. 1993. PMID: 8229020

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

390 results

Search Page